Trappings of female liberation found amongst ISIS sex slaves in Iraq

isis

 

Apparently, according to the Quran, a man may not lay with a woman who is already bearing a child. This is, according to the readings, so there is no confusion of paternity of the baby, once it’s born.  This gets complicated with ISIS and their female slaves. All they have to do is capture them to enslave them. Back in the old days, they waited  30 days after buying or capturing or a new slave to see if she has her menstrual period..

But now, No Muss, no fuss. These girls are having abortions, getting hormone injections of Depo provera, taking  birth control pills, the ‘day after’ pill and being hauled in for countless blood and urine tests to make sure they are not with child.

 

We associate contraception with women’s lib. This is anything but. They are making the reproductive decisions for the women themselves.

They are all for modern conveniences when it’s convenient.

These guys are in a hurry. After all, tomorrow they may go to Allah and all of those virgins in Paradise so they gotta move on what’s alive, in front of them and their property. When they tire of one, they give her away and procure another.

Raping a female slave is permitted in the Quran under any circumstance barring her being pregnant.

Shaking, rattling and Rolling Executives at FDA’s Orphan Development Dept re Generics gone sky hi!

Filenes basement is the best!!!! Check out this bright yellow dress for a happiness 'charge'!
Filenes basement is the best!!!! Check out this bright yellow dress for a happiness ‘charge’!

 

 

2-21-2016

Dear Dr. Conte,

(Head of FDA’s Orphan Drug Development Department)

 

I’ve been trying to reach you and am getting tired of my envelopes being returned with a handwritten ‘not us’ on them. Obviously you are somewhere at the FDA as the head of ‘Orphan Drug Development Department.’ So I’m trying again and am not likely to go away.

Recently my Tardive Dyskinesia medicine went up from 2.65 a month to 300.00. Naturally it was dropped by my part D formulary, who gave me no advance notice. I found out at the pharmacy, out of medication for this horrible condition and out of the new cash price.

I’m pretty sure it was reclassified ‘Orphan.’ I watched your video on your role in Orphan Drug Development, and was puzzled you only mentioned ‘new’ drugs, which we know from Valeant and Turing’s antics, is not so. Older drugs are being given this status.

I’m a writer for the Huffington Post ‘Stronger Together,” “The Arizona Republic” “Bipolar Magazine” and other publications concerned with this issue.

I tried to find out if consumers could view a list of pending applications for ‘Orphan’ status and came across document “Title 21” section 316.50 which said that The FDA does not make that information public. If consumers were able to follow market conditions affecting their medication as well as how many manufacturers there are along with mergers and acquisitions, this would be closer to a level playing field for the consumers.

I’m not out to skewer you or make you look inept, I just want to know if you are considering making certain helpful info available to the public so we aren’t the last to know about factors that greatly influence our health. If we knew in advance, for example, we could apply for Drug Company Assistance!

Please call me at 954-922-4310 or have one of your staff do the same. I’d love to get a quote on record and Maryland is very far from Florida. But I would be willing to make the trip just to ask you a few questions.

I’m only trying to calm consumers who currently are rather alarmed at the FDA ‘Orphan Drug Development’s’ lack of transparency.

 

Sincerely,

 

Allison Strong

Hollywood Florida

 

The story on the concentration of power in the hands of a few and unlimited pricing power is scary

The following is a fax I just wrote to my pharmacist, an indie who is really up on this stuff. He is the one who had my back; covering the inflated cost of my 62-year-old Benzo for Tardive Dyskinesia two months in a row thinking Medicare Part D would reimburse him. He took the loss two months in a row on my behalf. He’s got my back. do I have his????? This is what I ask myself and I urge you all…..skip the chains. Indies are where it’s at for cost and service. They get to know you and catch drug drug interactions and side effects your doctor might be too busy to catch. It’s their business and they are damned good at it.

 

2-22-16

Dear Ade,

Good Morning, The stories about monopolies and prescription drugs just keep getting worse.

I read this transcript of a testimony given for senate oversight committee of government reform re: prescription drugs. The guy’s name was Mark Merritt, claiming to head up the league of pharmacy benefit managers. He claims they leverage lower prices on prescriptions, bla, bla bla.

Then I read a New York Times article by a Yale University Endocrinologist who says that one of the three biggest PBM’s Actually IS CVS! Even tho insulin has been around forever, only three big companies control the market and have managed to keep tweaking their meds to extend patent protection all these decades. Her patient can’t afford the price of insulin once she hits the donut hole and can’t afford her medicine for the rest of the year because it’s too expensive and she doesn’t qualify for RX assistance or Medicaid. This is the situation I find myself in but I have more cash on hand than most.

Isn’t that a Conflict of Interest? She claims once her client hits the donut hole she can’t pay for her medicines and what’s worse, only three people …Lantus, Sanovi and Norvo Nordisc, make injectable insulin, a biologic, which has been extended patent protection for 12 years, not 7, and controls the insulin market until a biosimilar shows up. Every time I think I have the story figured out….it gets worse!!! Now I’m thinking of submitting a story to the Sun Sentinel. What have I got to lose? At least they are not compromised.

 

OK..More importantly,

I’m coming going out your way tomorrow to see the dentist so I have an RX list of stuff that’s close or due. I’m out of donut hole so I’m an aggressive consumer again, saving my extras for the months I can’t afford anything.

Here is the list: Valium, Metformin, Linzess, Lipitor. I’ll drop off the scripts. I see psychiatrist this week so anything we need I will find out from you.

Love,

Allison Strong

Shaking, rattling and Rolling Executives at FDA’s Orphan Development Dept re Generics gone sky hi!

Filenes basement is the best!!!! Check out this bright yellow dress for a happiness 'charge'!
Filenes basement is the best!!!! Check out this bright yellow dress for a happiness ‘charge’!

 

 

2-21-2016

Dear Dr. Conte,

(Head of FDA’s Orphan Drug Development Department)

 

I’ve been trying to reach you and am getting tired of my envelopes being returned with a handwritten ‘not us’ on them. Obviously you are somewhere at the FDA as the head of ‘Orphan Drug Development Department.’ So I’m trying again and am not likely to go away.

Recently my Tardive Dyskinesia medicine went up from 2.65 a month to 300.00. Naturally it was dropped by my part D formulary, who gave me no advance notice. I found out at the pharmacy, out of medication for this horrible condition and out of the new cash price.

I’m pretty sure it was reclassified ‘Orphan.’ I watched your video on your role in Orphan Drug Development, and was puzzled you only mentioned ‘new’ drugs, which we know from Valeant and Turing’s antics, is not so. Older drugs are being given this status.

I’m a writer for the Huffington Post ‘Stronger Together,” “The Arizona Republic” “Bipolar Magazine” and other publications concerned with this issue.

I tried to find out if consumers could view a list of pending applications for ‘Orphan’ status and came across document “Title 21” section 316.50 which said that The FDA does not make that information public. If consumers were able to follow market conditions affecting their medication as well as how many manufacturers there are along with mergers and acquisitions, this would be closer to a level playing field for the consumers.

I’m not out to skewer you or make you look inept, I just want to know if you are considering making certain helpful info available to the public so we aren’t the last to know about factors that greatly influence our health. If we knew in advance, for example, we could apply for Drug Company Assistance!

Please call me at 954-922-4310 or have one of your staff do the same. I’d love to get a quote on record and Maryland is very far from Florida. But I would be willing to make the trip just to ask you a few questions.

I’m only trying to calm consumers who currently are rather alarmed at the FDA ‘Orphan Drug Development’s’ lack of transparency.

 

Sincerely,

 

Allison Strong

Hollywood Florida